Compare BAX & MEDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BAX | MEDP |
|---|---|---|
| Founded | 1931 | 1992 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.4B | 13.4B |
| IPO Year | N/A | 2016 |
| Metric | BAX | MEDP |
|---|---|---|
| Price | $18.60 | $543.83 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 10 | 12 |
| Target Price | $25.67 | ★ $465.18 |
| AVG Volume (30 Days) | ★ 8.3M | 277.0K |
| Earning Date | 10-30-2025 | 10-22-2025 |
| Dividend Yield | ★ 0.22% | N/A |
| EPS Growth | N/A | ★ 25.36 |
| EPS | N/A | ★ 14.32 |
| Revenue | ★ $11,023,000,000.00 | $2,358,373,000.00 |
| Revenue This Year | $5.20 | $21.48 |
| Revenue Next Year | $2.02 | $11.90 |
| P/E Ratio | ★ N/A | $38.28 |
| Revenue Growth | 3.90 | ★ 13.88 |
| 52 Week Low | $17.40 | $250.05 |
| 52 Week High | $37.74 | $626.26 |
| Indicator | BAX | MEDP |
|---|---|---|
| Relative Strength Index (RSI) | 43.20 | 36.48 |
| Support Level | $18.33 | $530.96 |
| Resistance Level | $19.17 | $626.26 |
| Average True Range (ATR) | 0.54 | 18.24 |
| MACD | 0.21 | -8.14 |
| Stochastic Oscillator | 63.23 | 17.60 |
Baxter offers a variety of medical supplies and equipment to providers. From its legacy operations, Baxter sells injectable therapies for use in care settings, including IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. Baxter expanded its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment like hospital beds, operating room equipment, and patient monitoring tools to the portfolio. Baxter also sold its kidney care tools in early 2025.
Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical device firms. It also offers ancillary services, including bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has more than 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati, Ohio, and its operations are primarily based in the US, with additional presence in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.